We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Acerus Pharmaceuticals Corporation | TSX:ASP | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.36 | 0.36 | 0.44 | 0 | 01:00:00 |
Acerus has begun a process to search for a new CFO and will provide an update at a future date.
“I would like to thank Bob for his contributions over the past four years,” said Edward Gudaitis, President and Chief Executive Officer of Acerus Pharmaceuticals. “He has been a key contributor to our success, and we wish him the very best in the next phase of his career.”
About Acerus
Acerus Pharmaceuticals Corporation is a specialty pharmaceutical company focused on the commercialization and development of innovative prescription products that improve patient experience, with a primary focus in the field of men’s health. The Company commercializes its products via its own salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.
Acerus’ shares trade on TSX under the symbol ASP and on OTCQB under the symbol ASPCF. For more information, visit www.aceruspharma.com and follow us on Twitter and LinkedIn
Company Contactir@aceruspharma.com
Investor Relations ContactChris WittyAcerus Investor Relations(646) 438-9385cwitty@darrowir.com
1 Year Acerus Pharmaceuticals Chart |
1 Month Acerus Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions